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sives (1.8 ± 1.2 pg/ml) compared to normotensives (1.3 ± 0.9, p < 0.05), indicating 
persistent inflammation. The association between FMD and t-PA and TNF-~ remained 
significant after adjustments for cardiovascular isk factors. Thus, inflammatory and pro- 
thrombotic mediators play a role in the pathogenesis of atherosclerosis over and above 
the effects of classic risk factors. Antihypertensive therapy alone may be insufficient o 
improve endothelial dysfunction in hypertensives with high plasma levels of inflammatory 
markers. Additional therapy to target inflammation may be necessary to improve endot- 
helial function and to prevent progression of coronary atherosclerosis in high-risk hyper- 
tensives with subclinical inflammations. 
1011-96 Lipid Profile of Hypertensive Patients With 
Hyperl ipldemla and Coronary Artery Disease After 
Treatment With Nebivoloh A Beta-Blocker With 
Enhanced Nitric Oxide Release 
Rahul Aorawal. Albert Lichtenthal, Carsten Milbredt, Cardiopulmonary Department, 
Berlin.Chemie AG, Menarini Group, Berlin, Germany. 
Background: Antihypertensive therapy should ideally reduce LDL- and increase HDL-lev- 
els in hypertensive patients prone for cardiovascular disease. In the present multi-center 
observational study, the effects of nebivolol, a selective betal-receptor blocking agent 
which enhances endothelial nitric oxide (NO) release, were investigated in hypertensive 
patients with Hypedipidemia (HLP) and coronary artery disease (CAD). 
Methods: 8682 patients were included, average age 56.3+12.0 years, 53.8% males. Of 
these 3084 (35.5%) had HLP, 377 (4.3%) had additionally CAD. Besides systolic and 
diastolic blood pressure (BP), serum lipid values were measured before and after an 
average 59.7 days of treatment with nebivolol. According to the treating physicians co- 
medication and dietary habits remained unchanged. 
Results: The systolic and diastolic BP reduced in mean by 26.6+14.4 and 13.6_+9.0 
mmHg respectively. The LDL-levels decreased significantly from 156.7+42.5 to 
145.4+37.9 mg/dl (p<0,05). The HDL-levels increased significantly on the other hand 
under treatment from 48.8+19.1 to 48.8±16.3 mg/dl (p<0,05). 
Conclusions: Treatment with nebivolol ead to an increase in HDL-levels and a decrease 
in LDL-leve~s. The findings can only partly be explained by the BP lowering effect of 
nebivoloL A possible enhanced endothelial NO release, which has been shown for nebiv- 
olol previously, could explain the lipid lowering effects of this drug. Further studies are 
required to underline these results. 
1011-96A Effects of L ipid-Lowering Therapy With Flbretes on 
Endothelial Function In Patients With Type 2 Diabetes 
Mellltus 
Hideki Watanabe. Kunio Nakagawa, Maseaki Kakihana, KINU Medical Association 
Hospital, Mitsukaido, Japan, Ibaraki Prefectural University of Health Sciences, Aml, 
Japan. 
Dyslipidemia characterized by elevated triglyceride (TG) and reduced HDL-cholesterol 
(HDL-C) has been reported in patients with type 2 diabetes mellitus (DM). To evaluate 
effects of fibrates on endothelial functio, twenty-four type 2 diabetic patients with ele- 
vated TG (TG>150 mg/dL) were randomized to receive either fibrates (bezafibrate: B 
group, n=7; fenofibrate: F group, n=5) or placebo (n=12). By using ultrasound with a 7.5- 
MHz transducer, the brachial artery diameter was measured at rest and during reactive 
hyperemia (flow-mediated ilatation, FMD), and before and after 0.3 mg of sublingual 
nitroglycerin (nitroglycerin-induced dilatation, NID). These measurements were per- 
formed in 12-hour overnight fasting condition at baseline and after 3 months of the treat- 
ment. At baseline, there was no difference in lipid parameters, fasting glucose level, 
HbAlc, brachial artery diameters, %FMD (%incraase in diameter during hyperemia), and 
%NID (%increase in diameter after NTG) among three groups. After 3 months, triglycer- 
ide and LDL-C levels were significantly decreased, and HDL-C level was significantly 
increased in the fibrates groups (TG: B group, -38%, F group -45%; LDL-C: B group, - 
11%, F group -14%; HDL-C: B group, +18%, F group +19%). %FMD was improved after 
3 months of treatment with fibrates. On the other hand, %NID, fasting glucose level and 
HbAlc did not change after 3 months. Conclusion: Lipid-lowering therapy with fibrates 
might restore endothelial function in patients with type 2 DM. 
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1031-82 Sensitivity to Endothelin Is Increased in the Endothelial 
Dysfunction of Epicardiel Coronary Arteries in Left 
Vsntricular Hypertrophy in Swine 
Fanny Desiardins, Olivier Malo, Marie-Pierre Mathieu, Michel Carrier, Louis P. Perrault, 
Montreal Heart Institute, Montreal, Quebec, Canada. 
Background: We have recently demonstrated that NO-mediated endothelium-dependent 
relaxations are impaired in left ventricular hypertrophy (LVH) after 60 days of pressure 
ovedoad produced by aortic stenosis. Whether increased endothelium-dependent con- 
tractions contributes to this endothelial dysfunction is unknown. 
Objective: The aim of this project was to assess the sensitivity of endothelium-depondant 
vasoconstrictor ET-1 and endothelium-independent serotonin (5-HT) on the vascular 
smooth muscle of coronary artedes of swine submitted to 60 days of aortic banding. The 
plasmatic levels of the NO2-/NO3- ratio was measured to assess the production of NO in 
this model, 
Methods: Banding was performed through a left thoracotomy using umbilical tapes for 60 
days period, A minimal gradient of 15 mmHg was created by an aortic banding 3 cm 
above the coronary ostia. Development of LVH was documented by sedal echocardio- 
grams, Endothelium-dependent and independent contractions to ET-1 and 5-HT were 
studied by constructing dose-response curves in organ chamber experiments to evaluate 
the increase sensitivity to vasoconstriction (in the presence of indomethacin and propre- 
nolol), The plasma level of NO2-/NO3- was measured with a NO analyzer. 
Results: 60 days after aortic banding, there is an increase in endothelium-dependent 
contractions to ET-1 (P<0,05) and to 5-HT (P<0,05) compared to the control group. 
There is also a decrease in the NO2-/NO3- ratio 60 days after aortic stenesis (P<0,05), 
Conclusion: With the development of LVH secondary to aortic stenosis, the sensitivity of 
the vascular smooth muscle to ET-1 is increased as well as the sensitivity to 5-HT in cor- 
onary arteries. Decreased production of NO, could contribute to the increased tendency 
of epicardial coronary arteries to vasoconstriction. The dual mechanisms of endothelial 
dysfunction of decreased production of endothelial NO and increased sensitivity to vaso- 
constrictors may impair myocardial function by rendering cardiac muscle more suscepti- 
ble to ischemic injury. Pharmacological therapy should be both aimed at increasing 
endothelial NO and inhibiting ET-t to improve endothelial function of coronary arteries in 
LVH. 
1031-83 Chronic Selective Endothel in A Receptor Antagonism 
Preserves Myocardial Perfusion in Experimental 
Hypercholesterolemia 
Piero O. Booetti. Patricia J. Best, Martin Rodriguez-Porcel, David R. Holmes, Jr., Lilach 
O. Lerman, Amir Lerman, Division of Cardiovascular Diseases and Division of 
Hypertension, Mayo Clinic, Rochester, Minnesota, 
Expedmental hypercholesterolemia (HC) leads to coronary endothelial dysfunction, 
endothelin activation, increased vascular permeability, and attenuation of the myocardial 
perfusion (MP) response to increased myocardial demand, Chronic administration of 
endothelin A receptor (ETA) antagonists preserves coronary endothelial function in HC. 
However, whether this translates into preservation of MP is still unknown. Thus, the cur- 
rent study was designed to test the hypothesis that chronic ETA antagonism would pre- 
serve MP in HC. 
Methods: Pigs were randomized to 3 experimental groups: normal diet (N; n=7), high 
cholesterol diet (HC; n=7) and HC diet plus ABT-627, a selective ETA antagonist 
(HC+ABT-627; n=7) for 12 weeks, Electron beam computed tomography of the heart was 
performed before and during intravenous infusion of adenosine to calculate MP (ml/min/g 
myocardial tissue) and microvascular permeability index (PI; arbitrary units). 
Results: LDL-cholesterol was significantly and similarly increased in the HC and 
HC+ABT-627 group compared to N. As shown in the table, ABT-627 improved MP and 
preserved PI during adenosine infusion in HC. 
Conclusion: The current study demonstrates that chronic ETA antagonism with ABT-627 
preserves MP response to increased myocardial demand in HC in association with pres- 
ervation of microvascular permeability. This suggests a role for the endogenous endothe- 
lin system in the regulation of MP in pathophysiological states associated with 
endothelial dysfunction. 
Myocardial perfualon end mlcroveecular permeability Index at baseline 
and in response to adenosine 
N HC HC+ABT-627 
MP baseline 0.90+/-0. t 0.95+/-0.1 1 .o3+/-0.1 
MP adenosine 1.30+/-0.1 * 0.92+/-0.1 1.33+/-0.1 * 
% Change of MP to adenosine +48+/-7 -2+/-41" +29+/-6 
PI baseline 1.54+/-0.1 1 .34+/ -0 .2  1.62+/-0.1 
PI adenosine 1.73+/-0.2 2.26+/-0.2* 1.82+#0.1 
% Change of PI to adenosine +11+/-5 +78+/-131" +15+/-7 
* p < 0.001 vs baseline 
t P < 0.005 vs N and/or HC+S 
